Amp

Shock and outrage erupted as soon as word came that City College of San Francisco would decimate its cherished Older Adults program this spring in its latest round of cuts eliminating hundreds of credit and noncredit classes. “We fear the assault on older adults is just the first strike planned by Chancellor Mark Rocha,” Robert Fitch, who teaches in the Disabled Students program, said in an email to student advocates, one of many from faculty and students seeking help. “We need to call attention to this attack on older adults in San Francisco.” The decades-old program serves more than 2,000 people, many in their 70s and 80s, with 50 free, noncredit classes tailored to that age group. Many are held in senior centers and hospitals around the city. Students take tai chi for balance. They study music, figure drawing, theater, literature and writing to keep their minds sharp. They learn computer skills to stay connected to the world. And all the classes, they say, … [Read more...] about CCSF ends its Older Adults classes, leaving 2,000 students in the cold

French pharma giant Sanofi agreed to buy U.S. biotech company Synthorx Inc. for $2.5 billion, almost triple its market value, accelerating a push into cancer under new Chief Executive Officer Paul Hudson. Sanofi will pay $68 a share in cash for Synthorx, the companies said Monday. Shares of the unprofitable San Diego-based company closed at $25.03 Friday, having surged 40% last week. The deal underscores the Paris-based drugmaker's efforts to build its portfolio of innovative therapies in the fast-growing and lucrative cancer field. It was unveiled a day before Hudson outlines his pipeline and acquisition priorities, along with his initial plans for the consumer-health, diabetes and other units. The purchase marks Sanofi's first multibillion acquisition since early 2018. Investors are counting on Hudson to fire up Sanofi's research operations and step up the search for novel products to reduce its reliance on Dupixent, a standout medicine for severe eczema and asthma. Hudson, the … [Read more...] about Sanofi to buy Synthorx for $2.5 billion to expand in cancer

San Antonians made their way to see Luke Combs perform at the AT&T Center on Saturday, December 7, 2019. San Antonians made their way to see Luke Combs perform at the AT&T Center on Saturday, December 7, 2019. Photo: B. Kay Richter Photo: B. Kay Richter Image 1 of / 72 Caption Close Image 1 of 72 San Antonians made their way to see Luke Combs perform at the AT&T Center on Saturday, December 7, 2019. San Antonians made their way to see Luke Combs perform at the AT&T Center on Saturday, December 7, 2019. Photo: B. Kay Richter Photos: Luke Combs sings to sold out crowd at the AT&T Center 1  /  72 Back to Gallery Country star, Luke Combs,  made a stop in San Antonio on his … [Read more...] about Photos: Luke Combs sings to sold out crowd at the AT&T Center

STILLWATER, OK - NOVEMBER 30: Head coach Mike Gundy of the Oklahoma State Cowboys encourages his team before a "Bedlam" game against the Oklahoma Sooners on November 30, 2019 at Boone Pickens Stadium in Stillwater, Oklahoma. (Photo by Brian Bahr/Getty Images) less STILLWATER, OK - NOVEMBER 30: Head coach Mike Gundy of the Oklahoma State Cowboys encourages his team before a "Bedlam" game against the Oklahoma Sooners on November 30, 2019 at Boone Pickens Stadium in ... more Photo: Brian Bahr/Getty Images Photo: Brian Bahr/Getty Images Image 1 of / 1 Caption Close Image 1 of 1 STILLWATER, OK - NOVEMBER 30: Head coach Mike Gundy of the Oklahoma State Cowboys encourages his team before a "Bedlam" game against the Oklahoma Sooners on November 30, 2019 at Boone Pickens Stadium in Stillwater, … [Read more...] about Texas Bowl: Texas A&M vs. Oklahoma State

Shares of Airbus handily pulled ahead of rival Boeing this year after a pair of fatal 737 Max plane crashes led to the grounding of the U.S. model's entire fleet. Airbus is poised to finish the year ahead of Boeing for the first time since 2015, with an increase of roughly 50% since the start of January, compared to the Chicago-based company's less than 10% gain. With the uncertainty of approvals for the Max to resume flying, many analysts predict the French aircraft maker will continue to outperform its troubled peer in 2020 as well. Yet Airbus's own production issues at home amid trade concerns with the U.S. could also threaten its performance. "There is no question that Airbus has benefited from the problems at Boeing," Michael Hewson, chief market analyst at CMC Markets UK, said in an interview. In fact, he still believes the market is under-pricing problems at the U.S. manufacturer. Shares of both planemakers began 2019 at a brisk pace with Boeing and Airbus each up about 35% … [Read more...] about Airbus secures lead over Boeing as 737 Max uncertainty continues